Jeremy Touroo
Director at BioStar Capital
Gaylord, Michigan
Overview
Work Experience
Director
2015 - Current
A strategic venture capital partnership combining the insight of seasoned venture capitalists, practicing physicians with global reputations as medical thought leaders, and medical device experts to accelerate value creation for transformational medical device technologies in cardiovascular and orthopedic medicine.
NIH Center for Accelerated Innovations at Cleveland Clinic (NCAI-CC)
2018
External Selection Committee Technology Development Program - Cardiovascular, Lung, Blood, & Sleep Disorders (NHLBI)
Cleveland Clinic is a non-profit medical center that combines clinical and hospital care with research and education.
Raised $362,540,000.00 from National Institutes of Health, National Cancer Institute, National Institutes of Health, Agency for Healthcare Research and Quality, The Clorox Company, Charles L. Shor Foundation, National Institutes of Health, National Institutes of Health, LORD Corporation and Robert J. Fogarty.
Consulting Engineer
2016
Autonomix Medical is pioneering novel, catheter-integrated electrophysiologic technology for dramatically improved signal capture in clinical applications including cardiac mapping & ablation, neurostimulation, and nerve ablation.
Director, Bioengineering and Business Development
2014 - 2017
Research Engineer Scientist
2008 - 2014
An internationally established enterprise and joint initiative between the University of Louisville, Jewish Hospital, and St. Mary's HealthCare focused on the discovery, development, clinical translation, and commercialization of innovative technologies for cardiovascular disease through a world-class collaboration of scientists, engineers, and clinicians.
Electrical Engineering Intern
2005 - 2005
Motorola exists to invent, build and deliver the best mobile devices on the planet, improving the lives of millions of people.